46 results on '"Oomen, Agnes G"'
Search Results
2. Regulatory safety assessment of nanoparticles for the food chain in Europe
3. “Advanced materials” and the challenges on the horizon for testing their (eco)toxicity and assessing their hazard
4. Grouping of orally ingested silica nanomaterials via use of an integrated approach to testing and assessment to streamline risk assessment
5. Engineered Nanoparticles and Food: Exposure, Toxicokinetics, Hazards and Risks
6. Integrated approaches to testing and assessment for grouping nanomaterials following dermal exposure
7. Overview of potential adverse health effects of oral exposure to nanocellulose
8. Grouping Hypotheses and an Integrated Approach to Testing and Assessment of Nanomaterials Following Oral Ingestion
9. An Integrated Approach to Testing and Assessment to Support Grouping and Read-Across of Nanomaterials After Inhalation Exposure
10. Issues currently complicating the risk assessment of synthetic amorphous silica (SAS) nanoparticles after oral exposure
11. An integrated approach to testing and assessment of high aspect ratio nanomaterials and its application for grouping based on a common mesothelioma hazard
12. Mechanism of Action of TiO2: Recommendations to Reduce Uncertainties Related to Carcinogenic Potential
13. Possible Adverse Effects of Food Additive E171 (Titanium Dioxide) Related to Particle Specific Human Toxicity, Including the Immune System
14. A framework for grouping and read-across of nanomaterials- supporting innovation and risk assessment
15. Possible effects of titanium dioxide particles on human liver, intestinal tissue, spleen and kidney after oral exposure
16. Silicon dioxide and titanium dioxide particles found in human tissues
17. Nanomaterial grouping: Existing approaches and future recommendations
18. Risk assessment frameworks for nanomaterials: Scope, link to regulations, applicability, and outline for future directions in view of needed increase in efficiency
19. Risk assessment of titanium dioxide nanoparticles via oral exposure, including toxicokinetic considerations
20. Towards a nanospecific approach for risk assessment
21. Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the Dutch population
22. Dose metric for the prediction of toxicity of nanomaterials
23. Grouping nanomaterials to predict their potential to induce pulmonary inflammation
24. Horizon scan of nanomedicinal products
25. A practical approach to determine dose metrics for nanomaterials
26. Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study
27. Novel insights into the risk assessment of the nanomaterial synthetic amorphous silica, additive E551, in food
28. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats
29. Characterization of Titanium Dioxide Nanoparticles in Food Products: Analytical Methods To Define Nanoparticles
30. Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10
31. Considerations on the EU definition of a nanomaterial: Science to support policy making
32. Tissue Distribution of Inhaled Micro- and Nano-sized Cerium Oxide Particles in Rats: Results From a 28-Day Exposure Study
33. Knowledge gaps in risk assessment of nanosilica in food: evaluation of the dissolution and toxicity of different forms of silica
34. Presence of Nano-Sized Silica during In Vitro Digestion of Foods Containing Silica as a Food Additive
35. Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats
36. Presence and risks of nanosilica in food products
37. Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
38. What do we (need to) know about the kinetic properties of nanoparticles in the body?
39. Comparison of five in vitro digestion models to in vivo experimental results: Lead bioaccessibility in the human gastrointestinal tract
40. How Can Information on Oral Bioavailability Improve Human Health Risk Assessment for Lead-contaminated Soils? Implementation and Scientific Basis
41. Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment
42. Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food
43. Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
44. Nonequilibrium Solid-Phase Microextraction for Determination of the Freely Dissolved Concentration of Hydrophobic Organic Compounds: Matrix Effects and Limitations
45. Mobilization of PCBs and Lindane from Soil during in Vitro Digestion and Their Distribution among Bile Salt Micelles and Proteins of Human Digestive Fluid and the Soil
46. Comments on “Adsorption versus Absorption of Polychlorinated Biphenyls onto Solid-Phase Microextraction Coatings”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.